Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. ZEPP
  6. >
  7. Earnings
stocks logo

ZEPP Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Zepp Health Corp(ZEPP) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Zepp Health Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
-2025-11-04After Hours-------6.02-39.57
-2025-05-19After Hours-------6.34-10.21
FY2024Q42025-03-26After Hours--1.46-113.09M59.54M-47.35+15.33-1.33
-2024-08-21After Hours-------2.53-5.33
FY2024Q12024-05-20---0.23-45.41M39.70M-12.57+5.06-13.48
FY2023Q42024-03-18---0.02-94.57M83.31M-11.90+4.27-17.01
AI Stock Picker
AI Stock Picker

ZEPP Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Zepp Health Corp reported performance for , announced on 2025-11-04. The company achieved an EPS of , compared to analyst estimates of by % . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a -6.02% one-day change and a -39.57% five-day change following the earnings release. These movements reflect market reaction in Zepp Health Corp growth trajectory and strategic initiatives.

ZEPP Earnings Forecast

Looking ahead, Zepp Health Corp(ZEPP) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming , revenue estimates have been adjusted Go Down by -41.02% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Zepp Health Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between ZEPP's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-41.02%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:237.47M
--
EPS Estimate-Annual FY 2025:-0.12
—
Stock Price29.48
Financial AI Agent
Financial AI Agent

ZEPP Revenue and EPS Performance: A Historical Perspective

Zepp Health Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2025-11-04,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -6.02%(1-Day), -39.57%(5-Day)
(2025-05-19,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -6.34%(1-Day), -10.21%(5-Day)
FY2024Q4 (2025-03-26,After Hours):
EPS: -1.46 (Actual) vs. (Estimate) (%)
Revenue: 59.54M (Actual) vs. 113.09M (Estimate) (-47.35%)
Price Reaction: 15.33%(1-Day), -1.33%(5-Day)
Earnings Reaction
The chart below shows how ZEPP performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ZEPP sees a -1.00% change in stock price 10 days leading up to the earnings, and a -14.75% change 10 days following the report. On the earnings day itself, the stock moves by +3.82%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -6.02% on the day following the earnings release and then changed by -34.58% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Intellectia AI SwingMax
Intellectia AI SwingMax

Transcript Summary

Zepp Health Corp (ZEPP) Q3 2025 Earnings Call Summary
Positive
2025-11-04
The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.
Zepp Health Corp (ZEPP) Q2 2025 Earnings Call Summary
Positive
2025-08-04
The earnings call reveals a strong financial performance with a 46% YoY revenue increase and improved operating loss. Despite slight gross margin decline, management anticipates future expansion. The share repurchase program reflects confidence in long-term growth. Although there are concerns about management's vague responses, the product pipeline and strategic initiatives, like tariff mitigation, are promising. Given the positive Q3 guidance and shareholder value focus, the stock price is likely to rise 2-8%.
Zepp Health Corp (ZEPP) Q1 2025 Earnings Call Summary
Neutral
2025-05-21
The earnings call highlights positive aspects such as year-over-year revenue growth, gross margin expansion, and a share repurchase program, which are offset by increased operating expenses and foreign exchange headwinds. The Q&A session revealed management's lack of clarity on product launches and full-year performance guidance, which introduces uncertainty. Despite a strong product reception, macroeconomic challenges and competitive pressures remain concerns. The combination of these factors suggests a neutral stock price movement over the next two weeks.
Zepp Health Corp (ZEPP) Q1 2025 Earnings Call Summary
Neutral
2025-05-20
The earnings call presented mixed signals. While there is optimism in revenue growth and gross margin expansion, geopolitical risks and increased tariffs pose challenges. The share repurchase program is positive, but increased operating expenses and adjusted operating losses are concerning. The Q&A revealed uncertainties regarding tariffs and product launches, further contributing to a neutral outlook.
Zepp Health Corp (ZEPP) Q4 2024 Earnings Call Summary
Neutral
2025-03-27
The earnings call revealed mixed signals: a decline in revenue and gross margin due to supply chain issues and increased competition, but also improvements in gross margin for the full year and a narrowing operating loss. The continuation of the share repurchase program is positive. However, the lack of new product launches in 2024 and increased expenses could weigh on the stock. The Q&A section highlighted management's strategic efforts but also showed some areas of concern, like unclear responses on manufacturing and tax issues. Overall, these factors balance out to a neutral sentiment.
Zepp Health Corp (ZEPP) Q4 2024 Earnings Call Summary
Neutral
2025-03-27
The earnings call reveals mixed signals. Positive elements include a strategic focus on product innovation, market expansion, and a robust share repurchase program. However, the company faces challenges such as declining revenue, increased operating expenses, and a GAAP net loss. The Q&A section highlights management's evasive responses on critical issues like manufacturing shifts and tax impairments. The market's response is likely to be neutral, balancing optimism about future product launches and strategic partnerships with concerns about financial performance and competitive pressures.
Zepp Health Corp (ZEPP) Q4 2024 Earnings Call Summary
Neutral
2025-03-26
The earnings call reveals mixed signals: despite improved quarter-over-quarter sales and a commitment to product innovation, the company faces challenges like operating losses, investment impairments, and declining cash balances. The Q&A highlights management's strategic efforts, but also reveals some uncertainties. The stock repurchase program and product roadmap indicate confidence. However, the negative aspects such as investment impairments and operating losses balance out the positive signals, leading to a neutral sentiment prediction.
Zepp Health Corporation (ZEPP) Q3 2024 Earnings Call Summary
Positive
2024-11-19
The earnings call indicates strong financial performance, with record high gross margins and increased revenue from self-branded products. Despite some challenges like supply constraints and foreign exchange losses, the company shows optimism in resolving these issues and expects significant revenue growth in Q4. The expanded share buyback program reflects confidence in long-term strategy, and the focus on new product launches and strategic partnerships further supports a positive outlook. The Q&A session highlighted high demand and market opportunities, reinforcing a positive sentiment.
Zepp Health Corporation (ZEPP) Q2 2024 Earnings Call Summary
Positive
2024-08-22
The earnings call presents a mixed but overall positive outlook. Strong gross margins, a share buyback program, and narrowing net income losses are favorable. However, competitive pressures and regulatory risks are concerns. The Q&A highlights positive sentiment with improved gross margins and regional growth. Despite the operating loss, cost management and debt retirement are reassuring. The optimistic guidance on product launches and shareholder returns, combined with a record high gross margin, suggest a positive stock price movement in the short term.

People Also Watch

FAQ

arrow icon

What were the key highlights of ZEPP’s latest earnings report for ?

ZEPP reported its earnings on 2025-11-04, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a -6.02% price change on the earnings day and a -39.57% change over the next five days, reflecting market reactions to the results.
arrow icon

How did ZEPP’s stock price react after the earnings release?

Following ZEPP’s earnings announcement on 2025-11-04, the stock price moved by -6.02% on the day of the release. Over the subsequent five days, it saw a -39.57% change. Historically, ZEPP’s stock price tends to shift by an average of -1.00% in the 10 days leading up to earnings and -14.75% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for ZEPP for undefined?

For , analysts estimate ZEPP’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Down by -41.02% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does ZEPP’s stock price correlate with earnings forecast revisions?

The correlation between ZEPP’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Down by -41.02% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from ZEPP’s next earnings report?

Based on historical trends, ZEPP’s stock price typically moves by -1.00% in the 10 days before its earnings and -14.75% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .
arrow icon

What is the sentiment in Zepp Health Corp (ZEPP) Q3 2025 Earnings Call Summary?

The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free